regarding your message... I am just investing in NMPS, and you can call me whatever you want.
Value based perhaps? I am overjoyed with my finding this stock with a market cap surprisingly so low.
NMPS has full FDA approval for 2 products..NMP22 and NMP22 BladderChek product. Do you know how many companies never get FDA approval? many! Plus, the core technology seems to work for several other cancers.
With so few employees and low overhead one could see this company generating meaningful profits. Additionally, the bump up from more awareness of this and applicability to other cancers could drastically change the share price. Would a $750M market cap seem unreasonable? Well, that would be a share price in the $20's. It is not completely implausible to me.
Actually, there is a post on this board indicating there is a research report showing a $20 target price.